Clinical Trials Logo

Stage IVA Gallbladder Cancer clinical trials

View clinical trials related to Stage IVA Gallbladder Cancer.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT01859182 Withdrawn - Clinical trials for Advanced Adult Primary Liver Cancer

Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery

Start date: January 2013
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well selumetinib and Akt inhibitor MK-2206 work in treating patients with refractory or advanced gallbladder or bile duct cancer that cannot be removed by surgery. Selumetinib and Akt inhibitor MK-2206 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.